Previous study showed that GC patients with negative expression of Oct4 had worse prognosis than those with positive expression [20]; however, other report showed that Oct4 was expressed higher in GC tissues than non-cancerous tissues and associated with poor differentiation [21]. This evidence concerns the gene POU5F1 and gastric cancer.